英矽智能(03696)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03696 英矽智能

未开盘 06-17 16:08:37

33.680

+0.800

+2.43%

最高34.900	最低32.680	成交量230.91万
今开33.000	昨收32.880	日振幅6.75%
总市值192.52亿	流通市值192.52亿	总股本5.72亿
成交额7,820万	换手率0.40%	流通股本5.72亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03696","market":"HK","secType":"STK","nameCN":"英矽智能","latestPrice":33.68,"timestamp":1781683717007,"preClose":32.88,"halted":0,"volume":2309066,"delay":0,"changeRate":0.024330900243308914,"floatShares":571622000,"shares":571622000,"eps":-35.10311540149189,"marketStatus":"未开盘","change":0.8,"latestTime":"06-17 16:08:37","open":33,"high":34.9,"low":32.68,"amount":78199006,"amplitude":0.067518,"askPrice":33.68,"askSize":76500,"bidPrice":33.32,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-37.53212561900583,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781746200000},"marketStatusCode":0,"adr":0,"listingDate":1767024000000,"exchange":"SEHK","adjPreClose":32.88,"openAndCloseTimeList":[[1781659800000,1781668800000],[1781672400000,1781683200000]],"volumeRatio":0.486269,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03696/tweets","defaultTab":"tweets","newsList":[{"id":"2644794411","title":"港股异动 | 英硅智能(03696)早盘涨超6% 透脑NLRP3抑制剂首例患者给药 与衡泰生物合作达成首个临床里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=2644794411","media":"智通财经","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644794411?lang=zh_cn&edition=full","pubTime":"2026-06-17 10:09","pubTimestamp":1781662191,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，英硅智能早盘涨超6%，截至发稿，涨4.93%，报34.5港元，成交额2111.58万港元。消息面上，英硅智能宣布，与衡泰生物共同开发的ISM8969已达成首个临床里程碑，在I期临床研究中完成首例人体给药。公开资料显示，为加速该候选药物的全球开发，英硅智能与复星健康资本旗下深圳鹏复基金与复星医药的被投企业衡泰生物达成一项全球独家战略共同开发合作。随着项目进展，英硅智能有资格获得最高6600万美元的首付款及里程碑付款。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1455352.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","BK4588","BK1141","BK4585","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135918086","title":"异动解读｜英矽智能盘中上涨5.17%，ISM8969完成首例人体给药达成首个临床里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=1135918086","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135918086?lang=zh_cn&edition=full","pubTime":"2026-06-17 09:57","pubTimestamp":1781661461,"startTime":"0","endTime":"0","summary":"6月17日，英矽智能盘中上涨5.17%，报34.58港元/股，成交额1305.71万港元。消息面上，公司公告与深圳衡泰生物共同开发的ISM8969已达成首个临床里程碑，在I期研究中完成首例人体给药。ISM8969为一种具有潜在同类最佳潜力的口服小分子NLRP3炎症小体抑制剂，具备穿透血脑屏障能力，拟用于治疗慢性神经炎症及中枢神经系统疾病。根据协议，双方各持有该项目50%全球权益，英矽智能有权获得总额最高达6600万美元的预付款及里程碑付款。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644914597","title":"港股公告掘金 | 领益智造、芯碁微装等6家公司启动招股 百胜中国拟12亿美元购必胜客中国所有权","url":"https://stock-news.laohu8.com/highlight/detail?id=2644914597","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644914597?lang=zh_cn&edition=full","pubTime":"2026-06-17 09:21","pubTimestamp":1781659262,"startTime":"0","endTime":"0","summary":"【新股上市】领益智造(01688)今起招股 广发基金、惠理等多家机构基石认购 31.89 亿港元全球最大PCB直接成像设备供应商芯碁微装(09630)启动港股招股 合肥国资及多家头部机构基石认购15.81亿港元MERDEKAGOLD-DRS(06228)今起招股 平安资产管理、万国(03939)、嘉能可等多家基投认购约1.52亿美元国内模拟集成电路龙头圣邦股份(03661)启动港股招股 豪华基石团","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1455322.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0214","VXUS","BK0084","BK1588","LU0823426480.USD","LU1023057109.AUD","BK4209","LU2008162690.USD","002600","LU0228659784.USD","IE00B0JY6N72.USD","06675","BK4526","IE0003895053.USD","BK0132","HK0000320223.HKD","688630","LU0868486357.SGD","LU1051768304.USD","YUMC","BK4585","LU0029875118.USD","LU0320764755.SGD","BK1100","BK4588","BK1144","BK1233","LU0543330483.HKD","BK1617","LU0708994859.HKD","IE00BGV7N243.SGD","IPOS","LU0650527681.SGD","LU0327786744.USD","BK0081","LU0359201612.USD","BK1141","02252","LU0456842615.SGD","02889","HK0000306701.USD","LU2279701549.SGD","LU0310800379.SGD","LU0594300419.USD","BK4504","LU0128525929.USD","09987","03696","LU0572944931.SGD","LU0359202008.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644799674","title":"英硅智能(03696)与衡泰生物共同开发的ISM8969已达成首个临床里程碑，在I期研究中完成首例人体给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2644799674","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644799674?lang=zh_cn&edition=full","pubTime":"2026-06-17 08:32","pubTimestamp":1781656333,"startTime":"0","endTime":"0","summary":"智通财经APP讯，英硅智能 公布，公司与深圳衡泰生物科技有限公司共同开发的ISM8969已达成首个临床里程碑，在I期研究中完成首例人体给药。根据相关协议，英硅智能将授予衡泰生物对 ISM8969于全球范围内进行研究、开发、注册、生产和商业化的权利，双方各持有该项目50%的全球权益。与此同时，英硅智能有权获得总额最高达6,600万美元的预付款及里程碑付款。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1455311.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"英硅智能(03696)与衡泰生物共同开发的ISM8969已达成首个临床里程碑，在I期研究中完成首例人体给药","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108544461","title":"异动解读｜英矽智能盘中下跌5.1%，巨量解禁倒计时压力再度主导盘面","url":"https://stock-news.laohu8.com/highlight/detail?id=1108544461","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108544461?lang=zh_cn&edition=full","pubTime":"2026-06-16 10:07","pubTimestamp":1781575677,"startTime":"0","endTime":"0","summary":"6月16日，英矽智能盘中下跌5.1%，报32.76港元/股，成交额1700.95万港元。消息面上，公司基石投资者及员工限售股禁售期将于6月29日届满，届时约4.53亿股面临解禁，占总股本81.25%，前一交易日因获纳入中证指数系列短暂反弹后，市场对潜在集中减持压力的担忧再度发酵。基本面方面，公司营收同比下滑34.48%，归母净亏损3.52亿美元，盈利拐点尚未显现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146925201","title":"异动解读｜英矽智能盘中上涨5.61%，获纳入中证指数系列叠加富时全球指数纳入在即提振情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1146925201","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146925201?lang=zh_cn&edition=full","pubTime":"2026-06-15 09:45","pubTimestamp":1781487956,"startTime":"0","endTime":"0","summary":"6月15日，英矽智能盘中上涨5.61%，报36.28港元/股，成交额3092.03万港元。消息面上，公司当日正式获纳入中证指数系列，包括中证港股通创新药指数、中证香港创新药指数及中证港股通医药卫生综合指数，同日起生效；此外公司将于6月22日被纳入富时全球股票指数系列。双重指数纳入预期将吸引追踪相关指数的被动基金资金流入，提升股份流动性，短期情绪显著改善。不过公司约4.53亿股限售股禁售期将于6月29日届满，占总股本81.25%，潜在减持压力仍是后续关注焦点。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643233512","title":"英硅智能(03696)获纳入中证指数系列","url":"https://stock-news.laohu8.com/highlight/detail?id=2643233512","media":"智通财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643233512?lang=zh_cn&edition=full","pubTime":"2026-06-15 08:07","pubTimestamp":1781482043,"startTime":"0","endTime":"0","summary":"英硅智能(03696)公布，英硅智能获纳入中证指数系列，包括中证港股通创新药指数(代码：931250)、中证香港创新药指数(代码：931787) \n及中证港股通医药卫生综合指数(代码：930965)。此次纳入于2026年6月15日(星期一)起生效。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_27.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_27.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1454143.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"英硅智能(03696)获纳入中证指数系列","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107225696","title":"异动解读｜英矽智能盘中下跌5.01%，巨量解禁倒计时叠加基本面疲弱持续承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1107225696","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107225696?lang=zh_cn&edition=full","pubTime":"2026-06-11 09:57","pubTimestamp":1781143061,"startTime":"0","endTime":"0","summary":"6月11日，英矽智能盘中下跌5.01%，报31.46港元/股，成交额2380.59万港元。消息面上，公司基石投资者及员工限售股禁售期将于6月29日届满，届时约4.53亿股面临解禁，占总股本81.25%，当前股价较发行价仍有溢价，市场对潜在集中减持压力的担忧持续发酵。基本面方面，公司营收同比下滑34.48%，归母净亏损3.52亿美元，盈利拐点尚未显现。行业层面，生命科学工具和服务板块今日部分走弱，药明合联跌3.58%、晶泰控股跌2.87%，板块共振进一步拖累情绪。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113242200","title":"异动解读｜英矽智能盘中下跌5.09%，巨量解禁倒计时持续压制股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1113242200","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113242200?lang=zh_cn&edition=full","pubTime":"2026-06-10 10:14","pubTimestamp":1781057664,"startTime":"0","endTime":"0","summary":"6月10日，英矽智能盘中下跌5.09%，报31.94港元/股，成交额3001.86万港元。消息面上，公司基石投资者及员工限售股禁售期将于6月29日届满，届时约4.53亿股面临解禁，占总股本81.25%，当前股价较发行价仍有溢价，市场对潜在集中减持压力的担忧持续发酵。此外，公司营收同比下滑34.48%，归母净亏损3.52亿美元，基本面尚未形成有效支撑。生命科学工具和服务板块今日部分走弱，金斯瑞生物科技跌3.12%、药明合联跌3.01%、药明生物跌2.87%，行业共振进一步拖累情绪。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125801255","title":"异动解读｜英矽智能盘中下跌5.43%，巨量解禁倒计时叠加生命科学板块集体走弱","url":"https://stock-news.laohu8.com/highlight/detail?id=1125801255","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125801255?lang=zh_cn&edition=full","pubTime":"2026-06-09 11:25","pubTimestamp":1780975548,"startTime":"0","endTime":"0","summary":"6月9日，英矽智能盘中下跌5.43%，报33.8港元/股，成交额1.0亿港元。消息面上，公司基石投资者及员工限售股禁售期将于6月29日届满，届时约4.53亿股面临解禁，占总股本81.25%，市场对潜在减持压力的担忧持续加剧抛售。与此同时，生命科学工具和服务板块今日整体走弱，药明康德跌6.35%、金斯瑞生物科技跌5.13%、药明合联跌4.66%、药明生物跌4.54%、晶泰控股跌3.81%，行业共振进一步放大跌幅。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"656fb18d8db67173d094159d28d3c676","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164669532","title":"异动解读｜英矽智能盘中下跌5.69%，巨量解禁临近叠加行业板块整体走弱持续承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1164669532","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164669532?lang=zh_cn&edition=full","pubTime":"2026-06-08 10:22","pubTimestamp":1780885372,"startTime":"0","endTime":"0","summary":"6月8日，英矽智能盘中下跌5.69%，报35.8港元/股，成交额5462.07万港元。更关键的是，公司基石投资者及员工限售股禁售期将于6月29日届满，届时约4.53亿股面临解禁，潜在减持压力加剧抛售。此外，生命科学工具和服务板块今日整体走弱，药明生物跌5.44%，药明合联跌4.73%，金斯瑞生物科技跌4.33%，行业共振进一步放大跌幅。近一个月公司股价累计跌幅已近40%，颓势延续。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"656fb18d8db67173d094159d28d3c676","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641174678","title":"英硅智能(03696)获纳入富时全球股票指数系列","url":"https://stock-news.laohu8.com/highlight/detail?id=2641174678","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641174678?lang=zh_cn&edition=full","pubTime":"2026-06-08 08:20","pubTimestamp":1780878054,"startTime":"0","endTime":"0","summary":"智通财经APP讯，英硅智能 发布公告，根据富时罗素关于富时全球股票指数系列的季度检讨结果，英硅智能将被纳入(纳入)富时全球股票指数系列，包括富时全球小盘股指数、富时全球全盘指数 、富时全球总盘指数。富时全球股票指数系列提供了稳健的全球股票指数框架，该系列横跨全球49个发达和新兴市场，涵盖19,000多只大、中、小盘和微盘股票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1451174.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186267724","title":"异动解读｜英矽智能盘中上涨5.37%，生命科学板块整体走强叠加超跌反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=1186267724","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186267724?lang=zh_cn&edition=full","pubTime":"2026-06-05 09:54","pubTimestamp":1780624453,"startTime":"0","endTime":"0","summary":"6月5日，英矽智能盘中上涨5.37%，报39.1港元/股，成交额3255.95万港元。消息面上，该股此前因阿布扎比二次上市预期落空及6月29日约4.53亿股（占总股本81.25%）巨量解禁临近，近一个月累计跌幅近40%，短期抛压充分释放后迎来技术性反弹。同时，生命科学工具和服务板块今日整体走强，康龙化成涨4.19%，药明康德涨3.24%，药明生物涨2.53%，板块联动提振情绪。基本面方面，公司与礼来达成最高27.5亿美元AI制药合作、成立长寿委员会等积极进展为股价提供底部支撑。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161495775","title":"英矽智能5月股份变动月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1161495775","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161495775?lang=zh_cn&edition=full","pubTime":"2026-06-04 16:51","pubTimestamp":1780563106,"startTime":"0","endTime":"0","summary":"英矽智能于2026年6月4日发布截至2026年5月31日止月份的证券变动月报，披露当月并无新增股份发行、回购或注销。公告显示，英矽智能本月末法定/注册股本数量仍为1,270,000,000股，每股面值USD 0.0000005，对应注册股本总额USD 635，与上月末持平。已发行股份数量为572,402,000股，库存股份数量为0股，两项均较上月无变动，公司确认满足至少15%的公众持股量规定。在股权激励方面，英矽智能首次公开发售前股权激励计划期权本月减少2,224份已失效期权后，期末结存27,768,973份。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168700791","title":"异动解读 | 英矽智能盘中大跌5.56%，阿布扎比二次上市预期落空叠加解禁压力与行业疲软","url":"https://stock-news.laohu8.com/highlight/detail?id=1168700791","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168700791?lang=zh_cn&edition=full","pubTime":"2026-06-02 09:53","pubTimestamp":1780365214,"startTime":"0","endTime":"0","summary":"英矽智能今日盘中股价出现大幅下跌。消息面上，公司此前发布公告明确澄清，目前尚无任何在阿布扎比进行第二上市的确切计划。市场此前对该举措抱有较高期望，认为其将有助于拓展国际融资渠道并深化中东战略布局，预期的落空对市场情绪形成持续压制。与此同时，公司自去年12月登陆港股后，目前已正式进入解禁窗口期，部分基石投资者及员工持有的限售股面临到期，市场对潜在减持压力的担忧加剧了抛售行为。此外，生命科学工具和服务板块今日整体表现疲弱，行业环境不佳也进一步拖累了该股的表现。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170933436","title":"异动解读｜英矽智能盘中下跌5.26%，阿布扎比二次上市预期落空叠加解禁窗口压力持续承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1170933436","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170933436?lang=zh_cn&edition=full","pubTime":"2026-06-02 09:50","pubTimestamp":1780365008,"startTime":"0","endTime":"0","summary":"6月2日，英矽智能盘中下跌5.26%，报37.56港元/股，成交额2692.89万港元。消息面上，公司此前发布公告明确澄清目前尚无任何在阿布扎比进行第二上市的确切计划，市场此前预期该举措将拓展国际融资渠道并深化中东战略布局，预期落空持续压制情绪。与此同时，公司去年12月登陆港股，当前已正式进入解禁窗口期，部分基石投资者及员工限售股面临到期，市场对潜在减持压力的担忧加剧抛售行为。近一个月公司股价累计跌幅已近40%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640980880","title":"英硅智能(03696)股价续跌近7% 近1个月累计跌近40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640980880","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640980880?lang=zh_cn&edition=full","pubTime":"2026-06-01 11:24","pubTimestamp":1780284269,"startTime":"0","endTime":"0","summary":"金吾财讯 | 英硅智能(03696)股价整体延续近期下行趋势，早盘继续走弱，最新跌6.93%，报38.7港元。值得一提的是，近1个月公司股价累计跌幅近40%。公司此前发布公告称，公司谨此知会股东及投资者，公司不时考虑及评估上市后的各项资本运作，包括于其他资本市场进行第二上市之可行性。然而，公司目前尚无任何第二上市确实计划。","market":"sg","thumbnail":"https://static.szfiu.com/news/20200908/YzIxOTk5NDIxODE3ODE=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/YzIxOTk5NDIxODE3ODE=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1982627","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145181337","title":"异动解读 | 阿布扎比二次上市预期落空叠加解禁窗口压力，英矽智能盘中大跌6.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=1145181337","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145181337?lang=zh_cn&edition=full","pubTime":"2026-06-01 10:11","pubTimestamp":1780279897,"startTime":"0","endTime":"0","summary":"英矽智能今日盘中股价出现大跌，跌幅达6.49%，引发了市场关注。消息面上，公司此前发布公告，明确澄清目前尚无在阿布扎比进行第二上市的确切计划，这使得市场对其拓展国际融资渠道的预期落空，持续压制投资者情绪。与此同时，公司已正式进入上市后的解禁窗口期，部分基石投资者及员工持有的限售股面临到期，市场对潜在减持压力的担忧加剧了抛售行为。此外，港股市场整体正面临年中的解禁潮冲击，宏观层面的流动性压力也放大了个股层面的情绪波动，共同导致了英矽智能股价在盘中的显著下跌。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106106468","title":"异动解读｜英矽智能盘中下跌5.48%，解禁窗口临近叠加阿布扎比二次上市预期落空持续承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1106106468","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106106468?lang=zh_cn&edition=full","pubTime":"2026-06-01 10:06","pubTimestamp":1780279579,"startTime":"0","endTime":"0","summary":"6月1日，英矽智能盘中下跌5.48%，报38.94港元/股，成交额7983.15万港元。消息面上，公司此前于5月27日发布自愿公告，明确澄清目前尚无任何在阿布扎比进行第二上市的确切计划，市场此前预期该举措将拓展国际融资渠道并深化中东战略布局，预期落空持续压制情绪。更关键的是，公司去年12月登陆港股，当前已正式进入6月解禁窗口期，部分基石投资者及员工期权限售股面临到期，市场对潜在减持压力的担忧加剧抛售行为。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156420103","title":"异动解读 | 英矽智能盘中大跌7.9%，阿布扎比二次上市预期落空叠加解禁忧虑","url":"https://stock-news.laohu8.com/highlight/detail?id=1156420103","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156420103?lang=zh_cn&edition=full","pubTime":"2026-05-29 10:00","pubTimestamp":1780020018,"startTime":"0","endTime":"0","summary":"英矽智能(03696)今日盘中股价大幅下挫，跌幅一度达到7.90%，引发了市场关注。消息面上，公司近期发布自愿公告，明确澄清目前尚无任何在阿布扎比进行第二上市的确切计划。此前市场曾预期此举将有助于公司拓展国际融资渠道并深化中东战略布局，预期的落空对短期市场情绪构成了直接压制。此外，公司于去年12月登陆港股市场，当前正临近部分早期投资者所持限售股的解禁窗口期。市场对潜在的股份减持压力存在普遍担忧，这种忧虑情绪进一步加剧了抛售行为，共同导致了股价在盘中的显著下跌。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://insilico.com","stockEarnings":[{"period":"1week","weight":0.0169},{"period":"1month","weight":-0.3566},{"period":"3month","weight":-0.3751},{"period":"6month","weight":0.4004},{"period":"ytd","weight":-0.0932}],"compareEarnings":[{"period":"1week","weight":-0.0039},{"period":"1month","weight":-0.0531},{"period":"3month","weight":-0.0466},{"period":"6month","weight":-0.0537},{"period":"1year","weight":0.0138},{"period":"ytd","weight":-0.0514}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"英矽智能是一家主要从事人工智能在制药领域研发的公司。该公司致力于药物发现引擎的研发，并从事联合用药的发现和开发，包括疾病靶点识别、新分子数据生成以及临床试验结果预测。","exchange":"SEHK","name":"英矽智能","nameEN":"INSILICO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"英矽智能(03696)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供英矽智能(03696)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"英矽智能,03696,英矽智能股票,英矽智能股票老虎,英矽智能股票老虎国际,英矽智能行情,英矽智能股票行情,英矽智能股价,英矽智能股市,英矽智能股票价格,英矽智能股票交易,英矽智能股票购买,英矽智能股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"英矽智能(03696)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供英矽智能(03696)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}